Detalles del proyecto
| Estado | Activo |
|---|---|
| Fecha de inicio/Fecha fin | 11/14/25 → 10/29/27 |
Financiación
- Johnson and Johnson Enterprise Innovation Incorporated: 27.850,00 US$
25-HN-44-JJ (NANORAY-312): A Phase 3 (Pivotal Stage) Study of NBTXR3 Activated by Investigator s Choice of Radiotherapy Alone or Radiotherapy in Combination with Cetuximab for Platinum-based Chemotherapy-Ineligible Elderly Patients with Locally Advanced H
- Yi, Sun (PI)
- Yang, Eddy (Former PI)